Improved control of tuberculosis and activation of macrophages in mice lacking protein kinase R

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Wu, Kangyun ^a,c   Koo, Jovanka ^a,d   Jiang, Xiuju ^a   Chen, Ran ^b   Cohen, Stanley N ^b   Nathan, Carl ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; PROTEIN KINASE INHIBITOR; PROTEIN KINASE R; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME ACTIVATION; ENZYME DEFICIENCY; ENZYME MECHANISM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION INHIBITION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TUBERCULOSIS; TUBERCULOSIS CONTROL; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS;

BACTERIA (MICROORGANISMS); MAMMALIA; MUS; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; APOPTOSIS; EIF-2 KINASE; INTERFERON-GAMMA; INTERLEUKIN-10; MACROPHAGE ACTIVATION; MICE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN KINASE INHIBITORS; TUBERCULOSIS;

EID: 84857127328     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030512     Document Type: Article

References (58)

1. Schwegmann A, Brombacher F, (2008) Host-directed drug targeting of factors hijacked by pathogens. Sci Signal 1: re8.
2. Chang AC, Zsak L, Feng Y, Mosseri R, Lu Q, et al. (2006) Phenotype-based identification of host genes required for replication of African swine fever virus. J Virol 80: 8705-8717.
3. Cohen SN, (2009) Microbial drug resistance: An old problem in need of new solutions. In: Relman DA, Hamburg MA, Choffnes EE, Mack A, editors. Microbial Evolution and Co-Adaptation:A Tribute to the Life and Scientific Legacies of Joshua Lederberg National Academies Press pp. 173-180 2009; Washington, DC.
4. Philips JA, Rubin EJ, Perrimon N, (2005) Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 309: 1251-1253.
5. Kuijl C, Savage ND, Marsman M, Tuin AW, Janssen L, et al. (2007) Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 450: 725-730.
6. Jayaswal S, Kamal MA, Dua R, Gupta S, Majumdar T, et al. (2010) Identification of host-dependent survival factors for intracellular Mycobacterium tuberculosis through an siRNA screen. PLoS Pathog 6: e1000839.
7. Kumar D, Nath L, Kamal MA, Varshney A, Jain A, et al. (2010) Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 140: 731-743.
8. Nathan CF, Kaplan G, Levis WR, Nusrat A, Witmer MD, et al. (1986) Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N Engl J Med 315: 6-15.
9. Nathan CF, Murray HW, Wiebe ME, Rubin BY, (1983) Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158: 670-689.
10. MacMicking J, Xie QW, Nathan C, (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350.
11. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, et al. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228.
12. Szuro-Sudol A, Nathan CF, (1982) Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells. J Exp Med 156: 945-961.
13. Tsunawaki S, Sporn M, Ding A, Nathan C, (1988) Deactivation of macrophages by transforming growth factor-beta. Nature 334: 260-262.
14. Bogdan C, Vodovotz Y, Nathan C, (1991) Macrophage deactivation by interleukin 10. J Exp Med 174: 1549-1555.
15. Oswald IP, Wynn TA, Sher A, James SL, (1992) Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci U S A 89: 8676-8680.
16. Saraiva M, O'Garra A, (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181.
17. Nathan C, (2009) Taming tuberculosis: a challenge for science and society. Cell Host Microbe 5: 220-224.
18. Torrado E, Robinson RT, Cooper AM, (2011) Cellular response to mycobacteria: balancing protection and pathology. Trends Immunol 32: 66-72.
19. Lu Q, Wei W, Kowalski PE, Chang AC, Cohen SN, (2004) EST-based genome-wide gene inactivation identifies ARAP3 as a host protein affecting cellular susceptibility to anthrax toxin. Proc Natl Acad Sci U S A 101: 17246-17251.
20. Anderson E, Cole JL, (2008) Domain stabilities in protein kinase R (PKR): evidence for weak interdomain interactions. Biochemistry 47: 4887-4897.
21. McKenna SA, Lindhout DA, Kim I, Liu CW, Gelev VM, et al. (2007) Molecular framework for the activation of RNA-dependent protein kinase. J Biol Chem 282: 11474-11486.
22. Cole JL, (2007) Activation of PKR: an open and shut case? Trends Biochem Sci 32: 57-62.
23. Garcia MA, Meurs EF, Esteban M, (2007) The dsRNA protein kinase PKR: virus and cell control. Biochimie 89: 799-811.
24. Chakrabarti A, Sadler AJ, Kar N, Young HA, Silverman RH, et al. (2008) Protein kinase R-dependent regulation of interleukin-10 in response to double-stranded RNA. J Biol Chem 283: 25132-25139.
25. Williams BR, (2001) Signal integration via PKR. Sci STKE 2001: re2.
26. Nakamura T, Furuhashi M, Li P, Cao H, Tuncman G, et al. (2010) Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 140: 338-348.
27. Nakayama Y, Plisch EH, Sullivan J, Thomas C, Czuprynski CJ, et al. (2010) Role of PKR and Type I IFNs in viral control during primary and secondary infection. PLoS Pathog 6: e1000966.
28. Seimon TA, Kim MJ, Blumenthal A, Koo J, Ehrt S, et al. (2010) Induction of ER stress in macrophages of tuberculosis granulomas. PLoS ONE 5: e12772.
29. Behar SM, Divangahi M, Remold HG, (2010) Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol 8: 668-674.
30. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, et al. (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 94: 5243-5248.
31. Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, et al. (2006) Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Seminars in immunology 18: 347-361.
32. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. The New England journal of medicine 345: 1098-1104.
33. Bryk R, Wu K, Raimundo BC, Boardman PE, Chao P, et al. (2011) Identification of new inhibitors of protein kinase R guided by statistical modeling. Bioorganic & medicinal chemistry letters 21: 4108-4114.
34. Sharma B, Altman JK, Goussetis DJ, Verma AK, Platanias LC, (2011) Protein Kinase R as Mediator of the Effects of Interferon (IFN) {gamma} and Tumor Necrosis Factor (TNF) {alpha} on Normal and Dysplastic Hematopoiesis. The Journal of biological chemistry 286: 27506-27514.
35. Bando Y, Onuki R, Katayama T, Manabe T, Kudo T, et al. (2005) Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease. Neurochem Int 46: 11-18.
36. Chang RC, Suen KC, Ma CH, Elyaman W, Ng HK, et al. (2002) Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J Neurochem 83: 1215-1225.
37. Goodman AG, Fornek JL, Medigeshi GR, Perrone LA, Peng X, et al. (2009) P58(IPK): a novel "CIHD" member of the host innate defense response against pathogenic virus infection. PLoS Pathog 5: e1000438.
38. Morel M, Couturier J, Lafay-Chebassier C, Paccalin M, Page G, (2009) PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease. J Cell Mol Med 13: 1476-1488.
39. Hu JH, Zhang H, Wagey R, Krieger C, Pelech SL, (2003) Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. J Neurochem 85: 432-442.
40. Divangahi M, Chen M, Gan H, Desjardins D, Hickman TT, et al. (2009) Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol 10: 899-906.
41. Pan H, Yan BS, Rojas M, Shebzukhov YV, Zhou H, et al. (2005) Ipr1 gene mediates innate immunity to tuberculosis. Nature 434: 767-772.
42. Hinchey J, Lee S, Jeon BY, Basaraba RJ, Venkataswamy MM, et al. (2007) Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J Clin Invest 117: 2279-2288.
43. Velmurugan K, Chen B, Miller JL, Azogue S, Gurses S, et al. (2007) Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog 3: e110.
44. Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, et al. (2004) The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428: 341-345.
45. Jo EK, Yang CS, Choi CH, Harding CV, (2007) Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors. Cell Microbiol 9: 1087-1098.
46. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, et al. (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285: 732-736.
47. Uetani K, Der SD, Zamanian-Daryoush M, de La Motte C, Lieberman BY, et al. (2000) Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase. J Immunol 165: 988-996.
48. Goh KC, deVeer MJ, Williams BR, (2000) The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J 19: 4292-4297.
49. Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, et al. (2000) Regulation of c-myc expression by IFN-gamma through Stat1-dependent and-independent pathways. EMBO J 19: 263-272.
50. Deb A, Haque SJ, Mogensen T, Silverman RH, Williams BR, (2001) RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway. J Immunol 166: 6170-6180.
51. Chomarat P, Rissoan MC, Banchereau J, Miossec P, (1993) Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med 177: 523-527.
52. Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, et al. (2006) IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24: 563-574.
53. Nathan C, Ding A, (2010) Nonresolving inflammation. Cell 140: 871-882.
54. Saraiva M, Christensen JR, Veldhoen M, Murphy TL, Murphy KM, et al. (2009) Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31: 209-219.
55. Vogt G, Nathan C, (2011) Differentiation of human macrophages in bitro with enhanced antimycobacterial activity. J Clin Invest In press.
56. Yang YL, Reis LF, Pavlovic J, Aguzzi A, Schafer R, et al. (1995) Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 14: 6095-6106.
57. Mhyre TR, Loy R, Tariot PN, Profenno LA, Maguire-Zeiss KA, et al. (2008) Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium. Neurobiol Aging 29: 1631-1643.
58. Kockx MM, (1998) Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol 18: 1519-1522.